Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines
U.K. guidelines for vaccinating HIV-infected adults against bacteria are based on limited data. We compared antibody responses between 211 HIV-infected and 73 HIV-uninfected adults vaccinated with pneumococcal polysaccharide vaccine (PPV) and Haemophilus influenzae b/meningococcal C polysaccharide-t...
Hoofdauteurs: | MacLennan, C, Richter, A, Hodson, J, Faustini, S, Birtwistle, J, Whitelegg, A, Chigiga, J, Singo, M, Walker-Haywood, J, Mulugeta, B, Masuka, S, Mainey, C, Plant, T, Drayson, M, Manavi, K |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Lippincott, Williams and Wilkins
2016
|
Gelijkaardige items
-
Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
door: Snape, MD, et al.
Gepubliceerd in: (2009) -
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
door: Francesca Micoli, et al.
Gepubliceerd in: (2023-05-01) -
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
door: Micoli, F, et al.
Gepubliceerd in: (2013) -
Impact and Control of Sugar Size in Glycoconjugate Vaccines
door: Giuseppe Stefanetti, et al.
Gepubliceerd in: (2022-09-01) -
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
door: Khatami, A, et al.
Gepubliceerd in: (2011)